trading (terminating at 11:59 EST on Sept. 22,2006) in the securities
of Southwestern (last trade was 8 cents per share) because of
questions that have been raised about the accuracy and adequacy of
publicly disseminated information concerning, among other things, the
existence of applications for U.S. Food and Drug Administration
approvals for its Labguard product, the existence of a patent and
trademark, and the receipt of an order for the sale of several
thousand units of Labguard."
Editor David J Phillips does not own any of the stock mentioned in
this article. You can see his portfolio holdings in the sidebar. The
No comments:
Post a Comment